Pharmaceuticals Market Research Reports

Pharmaceutical Market

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this industry. The pharmaceutical market, valued as a multi-billion dollar market, is undoubtedly the largest revenue generator for the life sciences industry.

The pharmaceutical industry can be divided into numerous market segments based on the different therapeutic areas and applications. The largest segment, the market for cardiovascular drugs, records huge sales every year. The rising world population, rapid ageing of the same, and an increased prevalence of diseases are the major factors driving growth of this industry. The recent breakthroughs in proteomics and genomics have led to the development of modernized approaches to drug discovery and development in the industry, for the possibility of newer, advanced, and more sophisticated therapies and drugs. Developments in biotechnology research have led to introduction of advanced therapies involving biopharmaceuticals, regenerative medicine, stem cells, etc. These new age therapies and products have caused ease of treatment procedures and enabled speedy recovery from various disorders. Technological growth in such interdisciplinary fields has opened up new arenas in drug discovery, drug delivery, and life sciences research.
Certain incurable diseases like cancer and AIDS, which are therapeutic areas of prime concern for scientists and doctors all over the world, depict immense growth potential for the pharmaceutical industry in the future. Surfacing of newer diseases and therefore, the rising requirement of newer drug delivery methods, explains the greater than before importance of research and development activities in the industry. Industry leaders now generously allocate around 20% of their turnover to R&D to allot the finest instruments and manpower for their use. This has helped them maintain a competitive edge over other players in the market. However, the high costs of R&D, shorter product life cycles, and trouble producing a ‘best-seller’ has introduced the trend of mergers, acquisitions, strategic alliances, and most importantly, outsourcing in the industry. Numerous companies have been entering into global tie-ups and collaborations pooling and utilizing their resources for R&D and new product development in almost all areas. With this ongoing and rapidly developing trend, countries have shown great interest in encouraging investments in developing R&D and manufacturing facilities by public funding and tax exemptions.

The industry, however, faces certain major challenges, one of them being the imbalance between the rate of introduction of novel drugs and that of patent expiry of the already existing brands. Rising research investments, development of better infrastructure, efficient allocation of resources, etc. are some of the measures adopted by players to cope with this problem. Stringent governmental regulation of this market in certain countries also sometimes restricts growth and causes loss of potential opportunities. However, certain regulatory measures such as patent protection for novel and blockbuster drugs helps manufacturers recover the massive investment costs incurred during the discovery, development, and commercialization of products. On the other hand, there are generic versions of drugs which are available at minimal prices as compared to patented drugs. These address the issue of affordability of drugs to the lower income groups.
Presently, the global pharmaceutical market is dominated by the United States. But huge double-digit growth rates are being observed in developing countries too, China and India being the best examples. This is mainly due to a large number of established multinational pharmaceutical companies outsourcing their research and manufacturing activities to these countries, owing to the favorable cost factor, modernized infrastructure, and a large and skilled base of scientifically knowledgeable manpower. Also, other emerging regional markets like Brazil, Russia, Germany, France, Spain, etc., continue to show tremendous growth in the pharmaceutical sector.

This section on pharmaceutical industry research consists of market research reports on its various segments like Cardiovascular drugs, Anesthesia drugs, Drug Discovery and Development, Dentistry, Dermatology, Blood and blood products, Clinical Diagnostics,  In vitro/Molecular Diagnostics, Radiology, Oncology, Dietary Supplements, Vaccines, Generics, and OTC drugs. The reports presented in this section include in-depth industry analysis involving major market players, latest market trends, new product developments, growth drivers, growth restrainers, market forecasts, and so on.

View More
TITLE Actions
Global Raloxifene Hydrochloride Market Data Survey Report 2025
Published in Nov 2018 | US $ 1500 Onwards | By HeyReport

Summary The global Raloxifene Hydrochloride market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market si...

Global Rasagiline Tablet Market Data Survey Report 2025
Published in Nov 2018 | US $ 1500 Onwards | By HeyReport

Summary The global Rasagiline Tablet market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, pro...

Global Remifentanil Hydrochloride Market Data Survey Report 2025
Published in Nov 2018 | US $ 1500 Onwards | By HeyReport

Summary The global Remifentanil Hydrochloride market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market ...

Global Small Animal Imaging Reagents Market Data Survey Report 2025
Published in Nov 2018 | US $ 1500 Onwards | By HeyReport

Summary The global Small Animal Imaging Reagents market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional mark...

Global Soft Gelatin Capsules Market Data Survey Report 2025
Published in Nov 2018 | US $ 1500 Onwards | By HeyReport

Summary The global Soft Gelatin Capsules market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size,...

Global Solid Organ Transplant Immunosuppressant Market Data Survey Report 2025
Published in Nov 2018 | US $ 1500 Onwards | By HeyReport

Summary The global Solid Organ Transplant Immunosuppressant market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Re...

Global Gabapentin Drug Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

Gabapentin (sold under the brand name Neurontin, among others) is a medication which is used to treat partial seizures, neuropathic pain, hot flashes, and restless legs syndrome. It is recommended as one of a number of first-line medica...

Global Ezetimibe Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

Ezetimibe is a drug that lowers plasma cholesterol levels. It acts by decreasing cholesterol absorption in the small intestine. It may be used alone (marketed as Zetia or Ezetrol), when other cholesterol-lowering medications are not tol...

Global Ezetimibe and Simvastatin Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

This combination medication is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Ezetimibe works by reducing the amount of cholesterol yo...

Global Eyedrops Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

This report studies the global market size of Eyedrops in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Eyedrops in these regions. This resea...

Global Esomeprazole Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

This report studies the global market size of Esomeprazole in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Esomeprazole in these regions. Th...

Global Drugs for Toxoplasmosis Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

This report studies the global market size of Drugs for Toxoplasmosis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drugs for Toxoplasmosis in th...

Global Doxercalciferol Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

Doxercalciferol (or 1-hydroxyergocalciferol, trade name Hectorol) is drug for secondary hyperparathyroidism and metabolic bone disease. It is a synthetic analog of ergocalciferol (vitamin D2). It suppresses parathyroid synthesis and sec...

Global Dexmethylphenidate Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

Dexmethylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). In 2017, the global Dexmethylphenidate market size was xx million US$ and is forecast to xx million US in 2025, growing at a CA...

Global Cosmetic Surgery and Service Market Size, Status and Forecast 2018-2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

This report focuses on the global Cosmetic Surgery and Service status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cosmetic Surgery and Service development in United States, E...

Global Conjugated Estrogen Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

Conjugated estrogen is an active pharmaceutical ingredient that contains a mixture of steroidal and non-steroidal components that are obtained from pregnant maresÂ’ urine. Conjugated estrogen is used as an external source and is prescrib...

Global Coenzyme Q10 Consumption Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

This report studies the global market size of Coenzyme Q10 Consumption in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Coenzyme Q10 Consumption in ...

Global Clindamycin phosphate Topical Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

Clindamycin Phosphate Topical, USP 1% is indicated in the treatment of acne vulgaris. In 2017, the global Clindamycin phosphate Topical market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of...

Global Clindamycin phosphate Injection Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

Clindamycin Injection, a water soluble ester of clindamycin and phosphoric acid, is a sterile solution for intramuscular or intravenous use. In 2017, the global Clindamycin phosphate Injection market size was xx million US$ and i...

Global Clindamycin phosphate for Vaginal Market Insights, Forecast to 2025
Published in Nov 2018 | US $ 3900 Onwards | By QYResearch Group

Clindamycin phosphate for Vaginal is used for the treatment of non-pregnant women = 18 years of age with bacterial vaginosis. In 2017, the global Clindamycin phosphate for Vaginal market size was xx million US$ and is forecast to...

We are on:

Need Help?